Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in
the livers of patients without a history of alcohol abuse. It is classified as either simple …

Background & Aims Cholangiocarcinoma (CCA) is a rare and heterogeneous biliary cancer,
whose incidence and related mortality is increasing. This study investigates the clinical …

Background Little is known about the epidemiology and patterns of care of intrahepatic
cholangiocarcinoma (iCCA) in daily clinical practice. The aims of this study were to estimate …

Context.—Cholangiocarcinoma (CCA) is a heterogeneous cancer of the bile duct, and its
diagnosis is often challenging. Objective.—To provide insights into state-of-the-art …

Cholangiocarcinoma is a tumor that arises as a result of differentiation of the cholangiocytes
and can develop from anywhere in the biliary tree. Subtypes of cholangiocarcinoma are …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and
causes major economic and health burdens throughout the world. Although the incidence of …

Objectives Cholangiocarcinoma (CCA) is a heterogeneous malignancy with high mortality
and dismal prognosis, and an urgent clinical need for new therapies. Knowledge of the CCA …

Cholangiocarcinoma (CCA) is a hepatic malignancy that has a rapidly increasing incidence.
CCA is anatomically classified into intrahepatic (iCCA) and extrahepatic (eCCA), which is …

Fatty liver diseases, such as non-alcoholic fatty liver disease (NAFLD), are global health
disparities, particularly in the United States, as a result of cultural eating habits and lifestyle …